Purchases and Sales Made in Q1 2024 in Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA) during Q1 2024. The information is specifically focused on institutions that hold shares of Lyra Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2024
Q1 2024
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
3.45K+ 20.61% |
$15.7K - $22.5K
|
20.2K
$4.04K
|
|
|
May 13, 2024
Q1 2024
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
2.66K+ 9.25% |
$12.1K - $17.4K
|
31.5K
$6.29K
|
|
|
May 14, 2024
Q1 2024
|
Macquarie Group LTD
Australia, C3 |
BUY
|
- |
1.38KNew |
$6.26K - $8.98K
|
1.38K
$275
|
|
|
May 15, 2024
Q1 2024
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
500+ 0.02% |
$2.28K - $3.27K
|
2.58M
$515K
|
|
|
May 15, 2024
Q1 2024
|
Northwestern Mutual Wealth Management CO
|
BUY
|
- |
100New |
$455 - $653
|
100
$20
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 1.62% |
$18.2 - $26.1
|
251
$50.2
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-1.05K- 1.71% |
$4.8K - $6.88K
|
60.5K
$12.1K
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-2.63K- 80.1% |
$12K - $17.2K
|
654
$131
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-4.22K- 86.58% |
$19.2K - $27.6K
|
654
$131
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-4.78K- 99.63% |
$21.8K - $31.2K
|
18
$3.6
|
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
SELL
|
- |
-5.57K- 4.47% |
$25.3K - $36.4K
|
119K
$23.8K
|
|
|
May 15, 2024
Q1 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-8.47K- 28.59% |
$38.5K - $55.3K
|
21.2K
$4.23K
|
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-17.3K- 6.91% |
$78.6K - $113K
|
233K
$46.5K
|
|
|
May 15, 2024
Q1 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-55K- 38.79% |
$250K - $359K
|
86.8K
$17.4K
|
|
|
May 15, 2024
Q1 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-113K- 14.92% |
$513K - $736K
|
642K
$128K
|
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-198K- 15.75% |
$899K - $1.29M
|
1.06M
$211K
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-258K- 8.58% |
$1.17M - $1.68M
|
2.74M
$548K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-747K- 92.07% |
$3.4M - $4.88M
|
64.4K
$12.9K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-747K- 92.07% |
$3.4M - $4.88M
|
64.4K
$12.9K
|
|
|
May 15, 2024
Q1 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-1.23M- 30.35% |
$5.59M - $8.03M
|
2.82M
$564K
|
|
|
May 13, 2024
Q1 2024
|
Vestal Point Capital, LP
New York, NY |
SELL
|
- |
-2.2M- 73.33% |
$10M - $14.4M
|
800K
$160K
|